We develop miniaturized implants utilizing our proprietary NanoPortalTM technology platform, which enables delivery of a broad range of medicines to treat chronic diseases. Our products, designed to address poor adherence, will significantly improve patients’ lives and provide assurance to the physicians who treat them.
The founders of Nano Precision Medical began their entrepreneurial journey by winning a series of business plan competitions and subsequently founding the company in 2009. NPM focused its early efforts on developing its foundational science and technology. After some breakthrough success in 2019, the company shifted towards pre-clinical and clinical stage development of our initial product, NPM-119 (exenatide implant).
Based on the founders’ experience at the University of California and its location in the heart of the San Francisco Bay Area, Nano Precision Medical maintains a culture of creativity, energy, and integrity, while relentlessly advancing its technology and products. Nano Precision Medical is dedicated to cultivating a company-focused, flexible, and driven team, determined to provide superior real-world outcomes and experiences to patients.